Incontinence Treatment Resulting From Prostate Cancer Surgery: Muscle-derived Stem Cells Prove Effective In Reparing Sphincter Damage To Restore Continence

Two studies presented at the 103rd Annual Scientific Meeting of the American Urological Association (AUA), show that patients with incontinence resulting from iatrogenic sphincter damage may benefit from stem cell therapy. Incontinence after a radical prostatectomy for the treatment of prostate cancer can be a result in damage to the external urinary sphincter and would [...]

The Senate Approves Additional Funding For Cancer Research

Today we can all celebrate because the Senate voted overwhelming to pass a supplemental appropriations bill that includes additional funding for cancer research. In a 75-22 vote, senators approved $400 million in additional funding for the National Institutes of Health (NIH). The effort to approve this legislation was spearheaded by Senator Tom Harkin (D-IA). We [...]

Understanding NCI: Toll-Free Teleconference on the Clinical Trials Advisory Committee

NCI’s Office of Advocacy Relations (OAR) will host its third teleconference, Understanding the Role of NCI’s Clinical Trials Advisory Committee, on Wednesday, May 21, from 2:00 – 3:00 p.m., EST. The featured speakers are: Dr. Sheila Prindiville, Director, Coordinating Center for Clinical Trials, NCI’s Office of the Director; Ms. Susan Leigh, Advocate Member, CTAC; Col. [...]

By |2021-02-22T10:05:38-05:00May 20th, 2008|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments
Go to Top